Apollo Hospitals Enterprise Ltd
Apollo Hospitals Enterprise Ltd (APOLLOHOSP) last reported results for the quarter ended Jun 2026, with sales of ₹7,044 crore and net profit of ₹610 crore. The stock last traded at ₹8,028, a market capitalisation of ₹1,15,408 crore, on a P/E of 54.9. Over the past 52 weeks the stock has ranged between ₹6,680 and ₹9,327. Figures are as of 9 Oct 2026 and are not real time.
Apollo Hospitals Enterprise Ltd share price and key metrics
- Current price
- ₹8,028
- Market cap
- ₹1,15,408 cr
- Stock P/E
- 54.9
- Book value
- ₹659
- ROE
- 21.2%
- ROCE
- 17.4%
- Dividend yield
- 0.25%
- 52w high / low
- 9327/6680
Metrics as of 9 Oct 2026. Not real time.
Track Apollo Hospitals Enterprise Ltd
Cruxal reads every Apollo Hospitals Enterprise Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Apollo Hospitals Enterprise Ltd growth and returns
- 10 Years
- 15%
- 5 Years
- 19%
- 3 Years
- 15%
- TTM
- 17%
- 10 Years
- 23%
- 5 Years
- 76%
- 3 Years
- 32%
- TTM
- 34%
- 10 Years
- 20%
- 5 Years
- 13%
- 3 Years
- 17%
- 1 Year
- 4%
- 10 Years
- 13%
- 5 Years
- 17%
- 3 Years
- 18%
- Last Year
- 21%
Apollo Hospitals Enterprise Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹7,044 cr, up 20.6% from ₹5,842 cr a year earlier. Net profit was ₹610 cr, up 38.3% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 5,589 | 5,527 | 5,592 | 5,842 | 6,304 | 6,477 | 6,606 | 7,044 |
| Expenses | 4,774 | 4,765 | 4,822 | 4,990 | 5,362 | 5,512 | 5,594 | 5,951 |
| Operating profit | 816 | 762 | 770 | 852 | 941 | 965 | 1,011 | 1,092 |
| OPM % | 15% | 14% | 14% | 15% | 15% | 15% | 15% | 16% |
| Other income | 44 | 69 | 72 | 54 | 61 | 48 | 54 | 62 |
| Interest | 118 | 110 | 115 | 108 | 110 | 113 | 119 | 120 |
| Depreciation | 184 | 185 | 211 | 215 | 218 | 219 | 224 | 235 |
| Profit before tax | 557 | 536 | 516 | 583 | 675 | 682 | 722 | 799 |
| Tax % | 29% | 29% | 20% | 24% | 27% | 24% | 24% | 24% |
| Net profit | 396 | 379 | 414 | 441 | 494 | 516 | 551 | 610 |
| EPS (₹) | 26.34 | 25.89 | 27.10 | 30.10 | 33.19 | 34.93 | 36.81 | 40.39 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Apollo Hospitals Enterprise Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7,256 | 8,243 | 9,617 | 11,247 | 10,560 | 14,663 | 16,612 | 19,059 | 21,794 | 25,228 | 26,430 |
| Operating profit | 734 | 801 | 1,070 | 1,591 | 1,140 | 2,189 | 2,065 | 2,394 | 3,033 | 3,779 | 4,010 |
| OPM % | 10% | 10% | 11% | 14% | 11% | 15% | 12% | 13% | 14% | 15% | 15% |
| Net profit | 131 | 60 | 200 | 432 | 137 | 1,108 | 844 | 935 | 1,505 | 2,003 | 2,172 |
| EPS (₹) | 15.88 | 8.44 | 16.96 | 32.70 | 10.46 | 73.42 | 56.97 | 62.50 | 100.56 | 135.04 | 145.32 |
TTM is the trailing twelve months to the most recent quarter.
Apollo Hospitals Enterprise Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 70 | 70 | 70 | 70 | 72 | 72 | 72 | 72 | 72 | 72 |
| Reserves | 3,244 | 3,182 | 3,264 | 3,270 | 4,531 | 5,551 | 6,126 | 6,864 | 8,140 | 9,408 |
| Borrowings | 3,125 | 3,427 | 3,673 | 3,596 | 4,160 | 4,068 | 4,332 | 5,333 | 7,864 | 8,493 |
| Other liabilities | 1,665 | 1,917 | 2,159 | 4,354 | 2,629 | 3,570 | 3,886 | 4,474 | 4,568 | 4,210 |
| Total liabilities | 8,103 | 8,596 | 9,166 | 11,289 | 11,392 | 13,261 | 14,416 | 16,742 | 20,644 | 22,183 |
| Fixed assets | 4,591 | 4,773 | 4,982 | 7,432 | 6,778 | 8,296 | 8,520 | 9,664 | 10,988 | 12,272 |
| CWIP | 347 | 712 | 822 | 236 | 234 | 46 | 610 | 873 | 921 | 1,032 |
| Investments | 406 | 352 | 462 | 434 | 1,343 | 816 | 574 | 986 | 2,487 | 2,179 |
| Other assets | 2,759 | 2,759 | 2,901 | 3,187 | 3,037 | 4,104 | 4,712 | 5,219 | 6,248 | 6,700 |
| Total assets | 8,103 | 8,596 | 9,166 | 11,289 | 11,392 | 13,261 | 14,416 | 16,742 | 20,644 | 22,183 |
As reported by the company. Total assets equal total liabilities by construction.
Apollo Hospitals Enterprise Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 623 | 537 | 905 | 1,293 | 1,265 | 1,696 | 1,377 | 1,920 | 2,136 | 2,856 |
| Cash from investing | -1,152 | -405 | -711 | -289 | -880 | -747 | -857 | -1,537 | -3,383 | -2,145 |
| Cash from financing | 477 | -108 | -215 | -910 | -340 | -792 | -633 | -311 | 1,319 | -478 |
| Net cash flow | -52 | 24 | -20 | 94 | 44 | 158 | -113 | 72 | 73 | 233 |
| Free cash flow | -46 | -84 | 233 | 782 | 984 | 1,044 | 252 | 785 | 439 | 925 |
| CFO / operating profit | 103% | 83% | 103% | 100% | 108% | 87% | 85% | 100% | 86% | 92% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Apollo Hospitals Enterprise Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 8% | 7% | 10% | 14% | 8% | 17% | 14% | 15% | 17% | 17% |
| Debtor days | 38 | 37 | 39 | 33 | 46 | 44 | 49 | 48 | 51 | 50 |
| Inventory days | 47 | 51 | 46 | 49 | 16 | 21 | 17 | 17 | 16 | 15 |
| Days payable | 51 | 55 | 56 | 60 | 74 | 79 | 82 | 88 | 72 | 63 |
| Cash conversion cycle | 34 | 33 | 29 | 22 | -12 | -14 | -16 | -23 | -6 | 3 |
| Working capital days | 27 | 8 | -3 | -8 | -4 | 5 | -1 | -19 | -6 | -25 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Apollo Hospitals Enterprise Ltd shareholding pattern
Promoters held 28.02% at Sep 2026, broadly unchanged since Sep 2025. FIIs 43.19% and DIIs 22.07%.
| % held | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 29.33% | 29.34% | 29.34% | 28.02% | 28.02% | 28.02% | 28.02% | 28.02% |
| FIIs | 45.27% | 42.74% | 43.49% | 44.20% | 43.54% | 42.62% | 41.49% | 43.19% |
| DIIs | 19.97% | 22.29% | 21.34% | 21.12% | 21.50% | 22.76% | 23.72% | 22.07% |
| Government | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% |
| Public | 5.21% | 5.41% | 5.61% | 6.43% | 6.71% | 6.39% | 6.53% | 6.49% |
| No. of shareholders | 1,27,802 | 1,34,058 | 1,41,007 | 1,60,556 | 1,78,648 | 1,74,610 | 1,74,281 | 1,72,863 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Apollo Hospitals Enterprise Ltd corporate filings
- Certificate under Regulation 74(5) for the period ended 30th September 2026 is enclosedCompany Updatelow impact
- Closure of Trading WindowInsider Trading / SASTlow impact
Cruxal's analysis: As per annexure enclosed
Read the full analysis - Apollo Hospitals issues notice for transfer of unclaimed shares to IEPFCompany Updatelow impact
Cruxal's analysis: Apollo Hospitals Enterprise Ltd has issued a notice regarding the mandatory transfer of…
Read the full analysis - Apollo Hospitals submits revised FY 2025-26 Annual Report due to editorial oversightOtherslow impact
Cruxal's analysis: Apollo Hospitals has submitted an updated version of its FY 2025-26 Annual Report…
Read the full analysis - Apollo Hospitals Enterprise Limited secures shareholder approval for 750 crore INR debt issuance and board re-appointments at 45th AGMAGM/EGMmedium impact
Cruxal's analysis: Apollo Hospitals Enterprise Limited has successfully concluded its 45th Annual General…
Read the full analysis - Apollo Hospitals Enterprise Ltd announces outcome of analyst/investor meetingCompany Updatelow impact
Cruxal's analysis: Apollo Hospitals Enterprise Ltd has filed the outcome of its analyst/investor meeting…
Read the full analysis - Apollo Hospitals Enterprise Ltd announces outcome of analyst/investor meetCompany Updatelow impact
Cruxal's analysis: Apollo Hospitals has filed the outcome of its analyst/investor meeting held on August 13…
Read the full analysis - Apollo Hospitals Enterprise Q1 FY27 Results: Strong 34% PAT Growth and Strategic Progress on HealthCo ListingCompany Updatehigh impact
Cruxal's analysis: Apollo Hospitals Enterprise Limited reported robust Q1 FY27 consolidated financial…
Read the full analysis - Apollo Hospitals Enterprise Ltd schedules analyst/investor meetingCompany Updatelow impact
Cruxal's analysis: Apollo Hospitals has issued an intimation regarding an upcoming analyst/investor meeting…
Read the full analysis - Apollo Hospitals Enterprise Ltd releases press material regarding quarterly financial performanceCompany Updatelow impact
Cruxal's analysis: Apollo Hospitals has filed a press release under Regulation 30 of the SEBI (LODR)…
Read the full analysis - Apollo Hospitals Reports Strong Q1 FY27 Results with 21% Revenue Growth and 28% EBITDA ExpansionResulthigh impact
Cruxal's analysis: Apollo Hospitals Enterprise Limited reported robust Q1 FY27 financial results, with…
Read the full analysis - Apollo Hospitals Recommends INR 10 Final Dividend for FY26, Announces 45th AGM DetailsCompany Updatemedium impact
Cruxal's analysis: Apollo Hospitals Enterprise Limited has announced the recommendation of a final dividend…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.